top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Eleftha 440mg Injection

Eleftha 440mg Injection

Manufacturer/Marketed By : INTAS PHARMACEUTICALS LTD

$204.47 $83.83

Eleftha 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

TRASTUZUMAB

Active Pharmaceutical Ingredient

Eleftha 440mg Injection

SKU INTAS PHARMACEUTICALS LTD
Original price

$204.47

Sale price

$83.83

Eleftha 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins. Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose. Eleftha 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

Active Pharmaceutical Ingredient

TRASTUZUMAB

Uses

• Advanced and metastatic breast cancer
• Metastatic gastric cancer

Benefits

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Eleftha 440mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Most Common Side Effects

• Fever
• Visual disturbances
• Nose bleeds or runny nose
• Hair loss
• Dizziness
• Nail disorders
• Weight loss
• Loss of appetite
• Bruising
• Dry mouth
• Liver  inflammation
• Muscle pain
• Asthma/ lung disorders

Common Side Effects

• Heart Problems
• Allergic reactions
• Kidney problems
• Breathing difficulties

How To Use

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Safety Advice

• Breast Feeding: Avoid breastfeeding your baby while on the treatment with Eleftha 440mg Injection atleast for at least seven months after the final dose.
• Alcohol: Consult your doctor to know if it is safe to consume alcohol while you are on treatment with Eleftha 440mg Injection.
• Liver: You need to tell your physician if you have any liver disorders before starting Eleftha 440mg Injection as it requires dosage adjustment for severe liver impairment.
• Lungs: Talk to your doctor if you have any lung conditions before starting treatment with Eleftha 440mg Injection.
• Driving: Eleftha 440mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.
• Pregnancy: Discuss with your physician before taking this Eleftha 440mg Injection if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause to the unborn baby.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page